BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3119272)

  • 1. Clinical applications of thyrotrophin-releasing hormone.
    Griffiths EC
    Clin Sci (Lond); 1987 Nov; 73(5):449-57. PubMed ID: 3119272
    [No Abstract]   [Full Text] [Related]  

  • 2. TRH and diseases of the motor system.
    Munsat TL; Lechan R; Taft JM; Jackson IM; Reichlin S
    Ann N Y Acad Sci; 1989; 553():388-98. PubMed ID: 2497682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of motor neuron diseases using intrathecal TRH. Pilot study I].
    Patrignani Ochoa J; Morales Martínez D; Martínez Parra C
    Neurologia; 1988; 3(6):221-5. PubMed ID: 3152558
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyrotrophin-releasing hormone. New applications in the clinic.
    Griffiths EC
    Nature; 1986 Jul 17-23; 322(6076):212-3. PubMed ID: 3090448
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyrotrophin releasing hormone: endocrine and central effects.
    Griffiths EC
    Psychoneuroendocrinology; 1985; 10(3):225-35. PubMed ID: 2865764
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease.
    Guiloff RJ; Eckland DJ; Demaine C; Hoare RC; MacRae KD; Lightman SL
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1359-70. PubMed ID: 3119776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the clinical assessment of patients with motor neuron disease. Experience with a TRH analogue.
    Guiloff RJ; Eckland DJ
    Neurol Clin; 1987 Feb; 5(1):171-92. PubMed ID: 3104752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain?
    Metcalf G; Dettmar PW
    Lancet; 1981 Mar; 1(8220 Pt 1):586-9. PubMed ID: 6110823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal injury and thyrotrophin-releasing hormone.
    S Afr Med J; 1981 Dec; 60(24):917-8. PubMed ID: 6795728
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of TRH-T for the symptomatic treatment of the pathology of the upper motoneurons and electrophysiologic evaluation of its efficacy].
    Martinelli P
    Ann Ital Med Int; 1990; 5(3 Pt 2):262-9. PubMed ID: 2127688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate antagonists and thyrotropin-releasing hormone. II. Potential role in the treatment of central nervous system injury.
    Faden AI
    JAMA; 1984 Sep; 252(11):1452-4. PubMed ID: 6433052
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone (TRH) in murine motor neuron disease (the wobbler mouse).
    Kozachuk WE; Mitsumoto H; Salanga VD; Beck GJ; Wilber JF
    J Neurol Sci; 1987 May; 78(3):253-60. PubMed ID: 3108458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose TRH treatment of neuromuscular diseases: summary of mechanisms and critique of clinical studies. Summary of section IX.
    Engel WK
    Ann N Y Acad Sci; 1989; 553():462-72. PubMed ID: 2497686
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone and dementia.
    Sunderland T; Mellow AM; Gross M; Cohen RM; Tariot PN; Newhouse PA; Murphy DL
    Am J Psychiatry; 1986 Oct; 143(10):1318. PubMed ID: 3094388
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI; Hallenbeck JM; Brown CQ
    Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing hormone (TRH) and Alzheimer's disease.
    Peabody CA; Deblois TE; Tinklenberg JR
    Am J Psychiatry; 1986 Feb; 143(2):262-3. PubMed ID: 3080909
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy.
    Takeuchi Y; Miyanomae Y; Komatsu H; Oomizono Y; Nishimura A; Okano S; Nishiki T; Sawada T
    J Child Neurol; 1994 Jul; 9(3):287-9. PubMed ID: 7930408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term stability of single motor unit recordings in motor neuron disease: a macro EMG study.
    Guiloff RJ; Modarres-Sadeghi H; Stålberg E; Rogers H
    J Neurol Neurosurg Psychiatry; 1988 May; 51(5):671-6. PubMed ID: 3136230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury.
    Faden AI; Jacobs TP; Smith MT; Holaday JW
    Neurology; 1983 Jun; 33(6):673-8. PubMed ID: 6405303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.